Position in DXCM
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$377,395,050
-$20,289,780 QoQ
Shares Held
5,603,490
-11.5% QoQ
Ownership
1.48%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#14
of 966 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DXCM Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Amundi holds $3,367,612,014 across 33 Medical Devices names. DXCM ranks #5 (11.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
8,906,252 | $808,153,301 | |
| 2 | BSX |
Boston Scientific Corp
|
14,296,121 | $610,158,441 | |
| 3 | MDT |
Medtronic plc
|
5,824,040 | $455,614,643 | |
| 4 | SYK |
Stryker Corp
|
1,246,353 | $392,401,775 | |
| 5 | DXCM |
Dexcom Inc
This page
|
5,603,490 | $377,395,050 | |
| 6 | EW |
Edwards Lifesciences Corp
|
2,579,748 | $233,363,999 | |
| 7 | GEHC |
GE HealthCare Technologies Inc.
|
2,500,094 | $160,031,015 | |
| 8 | STE |
STERIS plc
|
513,373 | $108,100,950 |
All Filings in DXCM
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $377,395,050 | 5,603,490 | Shares | Defined | 2026-08-11 | |
| 2026-03-31 | $397,684,830 | 6,332,561 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $326,402,416 | 4,917,921 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $337,760,470 | 5,019,475 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $380,896,719 | 4,363,578 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $375,004,625 | 5,491,355 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $357,689,729 | 4,599,328 | Shares | Defined | 2025-02-07 | |
| 2024-09-30 | $257,009,631 | 3,833,676 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $285,533,576 | 2,518,377 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $305,451,237 | 2,202,244 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $305,804,409 | 2,464,376 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $240,207,282 | 2,574,569 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $299,346,303 | 2,329,362 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $222,823,940 | 1,917,920 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $204,124,492 | 1,802,583 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $137,480,887 | 1,706,989 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $109,042,450 | 1,463,068 | Shares | Defined | 2022-09-02 | |
| 2022-03-31 | $193,839,093 | 378,888 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $225,871,231 | 420,656 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $213,584,921 | 390,566 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $140,010,311 | 327,893 | Shares | Defined | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||